Kyntra Bio KYNB
NASDAQ KYNB
$5.24 -0.11 (-2.14%)
As of: Oct 21, 2026 · 12:37 PM EDT

Kyntra Bio (KYNB) Share-based Compensation (2014 - 2026)

Updated

Kyntra Bio (KYNB) posted Share-based Compensation of $984,000 for Q2 2026, down 47.5% from $1.87 million a year earlier and down 14.5% from the prior quarter.

Analysis

Kyntra Bio (KYNB) Share-based Compensation (2014 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Share-based Compensation at Kyntra Bio was $3.99 million, down 68.3% year-over-year; for FY2025, it was $6.58 million, down 73.9% from FY2024.

  • Annual Share-based Compensation has declined for five consecutive years, with a five-year compound annual growth rate of -38.2% (FY2020 to FY2025).
  • In prior years, Kyntra Bio's Share-based Compensation was $25.22 million in FY2024 (-50.3%), $50.77 million in FY2023 (-22.6%), $65.6 million in FY2022 (-7.8%) and $71.16 million in FY2021 (-2.1%).
  • Quarterly Share-based Compensation has run from a low of $178,000 in Q4 2024 to a high of $17.15 million in Q1 2022 over five years.
  • On a year-over-year basis, Share-based Compensation increased in 1 of the last eight quarters, with growth averaging 13.4%.
  • The strongest year-over-year quarter for Share-based Compensation in the past five years was Q4 2025, with growth of 568.0%; the weakest was Q4 2024, with a decline of 98.1%.
  • According to Business Quant data, Share-based Compensation for the three prior quarters was $1.15 million (Q1 2026), $1.19 million (Q4 2025) and $662,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Stock Comp. (Qtr)
1 Eli Lilly 1,135.99 Bn 1,104.58 Bn 19.71 Bn 201.00 Mn
2 Johnson & Johnson 616.90 Bn 535.42 Bn 17.26 Bn 458.00 Mn
3 AbbVie 501.56 Bn 474.68 Bn 12.70 Bn 166.00 Mn
4 Merck 367.41 Bn 321.79 Bn 12.21 Bn 298.00 Mn
5 Novartis Ag 297.75 Bn 261.74 Bn 11.24 Bn -
6 Astrazeneca 261.45 Bn 235.13 Bn 12.86 Bn -
7 Amgen 236.48 Bn 191.88 Bn 7.24 Bn 165.00 Mn
8 Gilead Sciences 190.56 Bn 164.76 Bn 6.22 Bn 231.00 Mn
9 Pfizer 169.46 Bn 116.11 Bn 10.94 Bn 249.00 Mn
10 Kyntra Bio 21.21 Mn -386.73 Mn 1.47 Mn 984,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 984,000.00
Mar 31, 2026 1.15 Mn
Dec 31, 2025 1.19 Mn
Sep 30, 2025 662,000.00
Jun 30, 2025 1.87 Mn
Mar 31, 2025 2.85 Mn
Dec 31, 2024 178,000.00
Sep 30, 2024 7.69 Mn
Jun 30, 2024 8.59 Mn
Mar 31, 2024 8.76 Mn
Dec 31, 2023 9.30 Mn
Sep 30, 2023 9.48 Mn
Jun 30, 2023 15.88 Mn
Mar 31, 2023 16.11 Mn
Dec 31, 2022 16.22 Mn
Sep 30, 2022 15.57 Mn
Jun 30, 2022 16.66 Mn
Mar 31, 2022 17.15 Mn
Dec 31, 2021 17.07 Mn
Sep 30, 2021 15.70 Mn
API Access

Kyntra Bio Share-based Compensation API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=share-based-compensation&ticker=KYNB&period=max&api_key=YOUR_API_KEY